[ Price : $8.95]
St. Jude Medical recalls Unify and Unify Assura cardiac resynchronization therapy defibrillators due to battery issues.[ Price : $8.95]
FDA warns Swedens Euro Diagnostica about Quality System and Medical Device Reporting violations in its manufacturing of Class 2 me...[ Price : $8.95]
FDA warns Diasol about QS violations in its New Jersey manufacturing and repacking facility.[ Price : $8.95]
Novo Nordisk asks FDA not to approve any ANDA for a drug referencing any of its liragltide-containing drugs and put restrictions o...[ Price : $8.95]
Pfizer tells FDA that an agency draft guidance on CMC postapproval manufacturing changes for specified biological products may con...[ Price : $8.95]
FDA accepts an Allergan NDA for ulipristal acetate, an investigational drug for treating abnormal uterine bleeding in women with u...[ Price : $8.95]
FDA issues a complete response letter for Mylans BLA for MYL-1401H, a proposed biosimilar of Amgens Neulasta (pegfilgrastim).[ Price : $8.95]
FDA releases its latest batch of Warning Letters that includes Diasol, Euro Diagnostica, Option Care, and Laveeza Bhatti.